The webinar will be hosted by Drug Target Review and will be presented by David Sykes, M.D., Ph.D., Researcher from Massachusetts General Hospital and Thibault Jonckheere, CEO and Séverine Giltaire, Senior Scientist from ImmunXperts.
The webinar features:
- Data obtained from a CRISPR/Cas9 screen to gain biological insights into Acute Myeloid Leukemia (AML) and identify new personalized therapies for patients.
- A high-throughput, multiparametric potency screen to evaluate the immunomodulatory potential of stem cells.
David Sykes M.D., Ph.D., Researcher, Massachusetts General Hospital
Thibault Jonckheere, CEO, ImmunXperts
Séverine Giltaire, Senior Scientist, ImmunXperts